dobutamine has been researched along with alprostadil in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ebata, T; Fujii, Y; Toyooka, H | 1 |
| McCabe, RD; Smith, PL | 1 |
| Berger, R; Frey, B; Hülsmann, M; Ioannides, C; Pacher, R; Stanek, B; Wutte, M | 1 |
| Berger, R; Globits, S; Heinz, G; Kreiner, G; Pacher, R; Presch, I; Radosztics, S; Rödler, S; Weber, H; Wutte, M | 1 |
| Berger, R; Hülsmann, M; Pacher, R; Siegel, A; Stanek, B; Wutte, M | 1 |
| Berger, R; Daneschvar, H; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Pacher, R; Rödler, S; Siegel, A; Stanek, B | 1 |
| Bauer, J; Dapper, F; Demirakça, S; Hagel, KJ; Knothe, C; Thul, J | 1 |
| Artemiou, O; Bîrsan, T; Klepetko, W; Kranz, A; Mares, P; Taghavi, S; Zuckermann, A | 1 |
| Berger, R; Bojic, A; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Locker, G; Pacher, R; Rödler, S; Stanek, B; Sturm, B | 1 |
| Howard, TK; Huddleston, CB; Zimmerman, AA | 1 |
| Frey, B; Hartter, E; Kos, T; Kubecova, L; Pacher, R; Spinar, J; Stanek, B; Vitovec, J; Wimmer, A; Yilmaz, N | 1 |
| Bojic, A; Frey, B; Hartter, E; Locker, G; Pacher, R; Stanek, B; Woloszczuk, W | 1 |
| Guo, CB; Jin, XQ; Kang, Q; Li, YC; Pu, CL; Yan, LN; Zhang, MM | 1 |
5 trial(s) available for dobutamine and alprostadil
| Article | Year |
|---|---|
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Digoxin; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Life Tables; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 1995 |
Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
Topics: Alprostadil; Analysis of Variance; Chronic Disease; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Single-Blind Method; Time Factors | 1994 |
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Topics: Alprostadil; Ambulatory Care; Antihypertensive Agents; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Epoprostenol; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Pilot Projects; Prospective Studies; Pulmonary Wedge Pressure; Risk Factors; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 1999 |
Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
Topics: Alprostadil; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Endothelins; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Renal Circulation; Vasodilator Agents | 1999 |
Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
Topics: Adult; Aged; Alprostadil; Ambulatory Care; Cardiotonic Agents; Dobutamine; Endothelin-1; Endothelins; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Long-Term Care; Male; Middle Aged; Prognosis; Prospective Studies; Protein Precursors; Survival Rate; Vascular Resistance; Vasodilator Agents | 2000 |
11 other study(ies) available for dobutamine and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Dobutamine increases diaphragmatic contractility in dogs.
Topics: Alprostadil; Anesthesia, Intravenous; Animals; Blood Pressure; Cardiac Output; Diaphragm; Dobutamine; Dogs; Drug Combinations; Electric Stimulation; Muscle Contraction; Nicardipine; Phrenic Nerve | 1992 |
Potassium secretion by rabbit descending colon: effects of adrenergic stimuli.
Topics: Alprostadil; Amiloride; Animals; Calcimycin; Chlorides; Colon; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Norepinephrine; Phenylephrine; Potassium; Rabbits; Sodium; Sympathomimetics; Terbutaline | 1986 |
Effect of prostaglandin E1 infusion on kidney function in patients with severe heart failure.
Topics: Alprostadil; Creatinine; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Vasodilator Agents | 1996 |
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Topics: Alprostadil; Cardiotonic Agents; Catheters, Indwelling; Chronic Disease; Disease Progression; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Safety; Treatment Outcome; Vasodilator Agents | 1997 |
Perioperative management of pulmonary hypertension after heart transplantation in childhood.
Topics: Alkalies; Alprostadil; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Cause of Death; Child; Child, Preschool; Cold Temperature; Dobutamine; Enoximone; Extracorporeal Circulation; Graft Rejection; Heart Transplantation; Humans; Hypertension, Pulmonary; Infant; Intraoperative Care; Opportunistic Infections; Phosphodiesterase Inhibitors; Postoperative Complications; Pulmonary Artery; Survival Rate; Time Factors; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 1997 |
Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension.
Topics: Adult; Alprostadil; Antihypertensive Agents; Cardiac Output, Low; Cardiotonic Agents; Catheterization, Swan-Ganz; Clonidine; Dobutamine; Echocardiography; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Transplantation; Male; Nifedipine; Respiratory Insufficiency; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 1999 |
Combined lung and liver transplantation in a girl with cystic fibrosis.
Topics: Adolescent; Alprostadil; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Catheterization, Swan-Ganz; Cystic Fibrosis; Dobutamine; Female; Fentanyl; Hemostasis, Surgical; Humans; Hypertension, Pulmonary; Hypotension; Intraoperative Complications; Isoflurane; Liver Transplantation; Lung Transplantation; Monitoring, Intraoperative; Patient Care Team; Vasodilator Agents | 1999 |
Early postoperative care of liver transplantation for infants with biliary atresia during pediatric intensive care unit stay.
Topics: Alprostadil; Bacterial Infections; Biliary Atresia; Body Weight; Cardiotonic Agents; Dobutamine; Dopamine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Infant; Intensive Care Units, Pediatric; Length of Stay; Liver Transplantation; Omeprazole; Organ Size; Postoperative Care; Postoperative Complications | 2010 |